Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Journal of Surgical Research
|
March 6, 2007
Development of a mouse model for evaluation of small diameter vascular grafts
Reynold I Lopez-Soler, Matthew P Brennan, Amit Goyal, et al.
Gynecologic Oncology
|
May 25, 2015
Stage I granulosa cell tumours: A management conundrum? Results of long-term follow up
Michelle K Wilson, Peter Fong, Soizick Mesnage, et al.
JCO Global Oncology
|
March 6, 2026
Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts
William Harris, Sarah Shirley, Elizabeth Liow, et al.
Kidney International Reports
|
September 19, 2022
Increased Rates of Supplement-Associated Oxalate Nephropathy During COVID-19 Pandemic
Peter Fong, Raghav Wusirika, Jose Rueda, et al.
Journal of Pediatric Surgery
|
March 29, 2006
Development of a model system for preliminary evaluation of tissue-engineered vascular conduits
Amit Goyal, Yinong Wang, Haili Su, et al.
British Journal of Cancer
|
February 16, 2023
A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours
Jayesh Desai, Peter Fong, Victor Moreno, et al.
Oncotarget
|
February 5, 2017
An association between overexpression of DNA methyltransferase 3B4 and clear cell renal cell carcinoma
You Liu, Liantao Sun, Peter Fong, et al.
Plos One
|
October 30, 2015
Gabapentin Effects on PKC-ERK1/2 Signaling in the Spinal Cord of Rats with Formalin-Induced Visceral Inflammatory Pain
Yan-Bo Zhang, Zheng-Dong Guo, Mei-Yi Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors
Johann S de Bono, Rebecca Kristeleit, Anthony Tolcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2014
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer
Johann S de Bono, Josep M Piulats, Hardev S Pandha, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Journal of Surgical Research
|
March 6, 2007
Development of a mouse model for evaluation of small diameter vascular grafts
Reynold I Lopez-Soler, Matthew P Brennan, Amit Goyal, et al.
Gynecologic Oncology
|
May 25, 2015
Stage I granulosa cell tumours: A management conundrum? Results of long-term follow up
Michelle K Wilson, Peter Fong, Soizick Mesnage, et al.
JCO Global Oncology
|
March 6, 2026
Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts
William Harris, Sarah Shirley, Elizabeth Liow, et al.
Kidney International Reports
|
September 19, 2022
Increased Rates of Supplement-Associated Oxalate Nephropathy During COVID-19 Pandemic
Peter Fong, Raghav Wusirika, Jose Rueda, et al.
Journal of Pediatric Surgery
|
March 29, 2006
Development of a model system for preliminary evaluation of tissue-engineered vascular conduits
Amit Goyal, Yinong Wang, Haili Su, et al.
British Journal of Cancer
|
February 16, 2023
A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours
Jayesh Desai, Peter Fong, Victor Moreno, et al.
Oncotarget
|
February 5, 2017
An association between overexpression of DNA methyltransferase 3B4 and clear cell renal cell carcinoma
You Liu, Liantao Sun, Peter Fong, et al.
Plos One
|
October 30, 2015
Gabapentin Effects on PKC-ERK1/2 Signaling in the Spinal Cord of Rats with Formalin-Induced Visceral Inflammatory Pain
Yan-Bo Zhang, Zheng-Dong Guo, Mei-Yi Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors
Johann S de Bono, Rebecca Kristeleit, Anthony Tolcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2014
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer
Johann S de Bono, Josep M Piulats, Hardev S Pandha, et al.
Page
of 3